Fibroblast growth factor 23 and adverse clinical outcomes in chronic kidney disease

Tamara Isakova*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

44 Scopus citations

Fingerprint

Dive into the research topics of 'Fibroblast growth factor 23 and adverse clinical outcomes in chronic kidney disease'. Together they form a unique fingerprint.

INIS

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science